Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Accumulated Expenses (2016 - 2025)

INVO Fertility (IVF) has disclosed Accumulated Expenses for 15 consecutive years, with $342957.0 as the latest value for Q3 2025.

  • Quarterly Accumulated Expenses fell 46.42% to $342957.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $342957.0 through Sep 2025, down 46.42% year-over-year, with the annual reading at $713483.0 for FY2024, 1.21% down from the prior year.
  • Accumulated Expenses for Q3 2025 was $342957.0 at INVO Fertility, down from $365694.0 in the prior quarter.
  • The five-year high for Accumulated Expenses was $1.9 million in Q1 2025, with the low at $342957.0 in Q3 2025.
  • Average Accumulated Expenses over 5 years is $720068.3, with a median of $641823.0 recorded in 2022.
  • The sharpest move saw Accumulated Expenses surged 211.5% in 2023, then crashed 46.42% in 2025.
  • Over 5 years, Accumulated Expenses stood at $581689.0 in 2021, then surged by 62.67% to $946262.0 in 2022, then fell by 23.67% to $722251.0 in 2023, then dropped by 1.21% to $713483.0 in 2024, then crashed by 51.93% to $342957.0 in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $342957.0, $365694.0, and $1.9 million for Q3 2025, Q2 2025, and Q1 2025 respectively.